Wei, Jiangxue Li, Zhengjun Yang, Yanli Ma, Xiaowei An, Wenqi Ma, Guanghui Su, Zhiguo Zhang, Songping
Here we present a biomimetic strategy towards an influenza vaccine design based on hepatitis B virus core virus-like particles (HBc VLP). To this end, a temperature-shift based encapsulation process based on analysis of the unique thermal-associated structural flexibility of HBc VLP nanocages was proposed and proved efficient for encapsulation of a...
Wei, Jiangxue Li, Zhengjun Yang, Yanli Ma, Guanghui Su, Zhiguo Zhang, Songping
Naturally occurring self-assembling ferritin nanoparticles have become widely appreciated for vaccine design. In this study, an apoferritin (AFt) nanocage was used as a carrier to construct a biomimetic influenza vaccine by encapsulating a conserved internal nucleoprotein (NP) antigen peptide inside the nanocage, followed by chemically conjugating ...
Jani, Meghna Chinoy, Hector Barton, Anne
Published in
The Journal of rheumatology
To identify (1) whether tumor necrosis factor inhibitor (TNFi) drug levels/anti-drug antibodies (ADAb) are associated with treatment response and disability in patients with psoriatic arthritis (PsA); and (2) the factors associated with TNFi drug levels. Patients were recruited from a national multicenter prospective cohort with longitudinal serum ...
Ji, Mei Zhu, Jie Xie, Xi-xiu Liu, Dong-qun Wang, Bin Yu, Zhuo Liu, Rui-tian
Personalized cancer vaccine which targets neoepitopes shows great promise for cancer treatment. However, rapid preparation is a critical challenge for clinical application of personalized cancer vaccine. Genetic recombination and chemical modification are a time-consuming "trial and error" pattern for making vaccines. Here we first constructed a pl...
de Geest, Bruno Ye, Tingting Zhong, Zifu García-Sastre, Adolfo Schotsaert, Michael
Published in
Angewandte Chemie (International Ed. in English)
The current COVID‐19 pandemic has a tremendous impact on daily life world‐wide. Despite the ability to dampen the spread of SARS‐CoV‐2, the causative agent of the diseases, through restrictive interventions, it is believed that only effective vaccines will provide sufficient control over the disease and revert societal live back to normal. At prese...
Van Hoecke, Lien Verbeke, Rein De Vlieger, Dorien Dewitte, Heleen Roose, Kenny Van Nevel, Sharon Krysko, Olga Bachert, Claus Schepens, Bert Lentacker, Ine
...
Published in
Molecular therapy. Nucleic acids
To date, mRNA-based biologics have mainly been developed for prophylactic and therapeutic vaccination to combat infectious diseases or cancer. In the past years, optimization of the characteristics of in vitro transcribed mRNA has led to significant reduction of the inflammatory responses. Thanks to this, mRNA therapeutics have entered the field of...
Ji, Mei Xie, Xi-xiu Liu, Dong-qun Lu, Shuai Zhang, Ling-xiao Huang, Ya-ru Liu, Rui-tian
Heterogenous aggregates of amyloid beta (A beta) and tau protein play a key role in Alzheimer's disease (AD) progression. As the epitope profiles of A beta and abnormally phosphorylated tau change over the course of the disease, tailor immunotherapy to specific patient groups according to the disease stage by targeting corresponding A beta and tau ...
Ji, Mei Xie, Xi-xiu Liu, Dong-qun Lu, Shuai Zhang, Ling-xiao Huang, Ya-ru Liu, Rui-tian
Heterogenous aggregates of amyloid beta (A beta) and tau protein play a key role in Alzheimer's disease (AD) progression. As the epitope profiles of A beta and abnormally phosphorylated tau change over the course of the disease, tailor immunotherapy to specific patient groups according to the disease stage by targeting corresponding A beta and tau ...
Liu, Jiangning Zhao, Binbin Xue, Ling Wu, Jing Xu, Yanfeng Liu, Yongdong Qin, Chuan
Background Prophylactic vaccines are critical in preventing hand, foot, and mouth disease (HFMD) primarily caused by human enterovirus 71 (EV71) infection. Children aged less than 5 years are especially susceptible to EV71 infections. In addition to the development of vaccines containing the inactivated virus, those containing virus-like particles ...
Deodhar, Atul Gladman, Dafna D McInnes, Iain B Spindeldreher, Sebastian Martin, Ruvie Pricop, Luminita Porter, Brian Safi, Jorge Jr Shete, Abhijit Bruin, Gerard
...
Published in
The Journal of rheumatology
Secukinumab, a fully human antiinterleukin 17A monoclonal antibody, is efficacious for the treatment of psoriatic arthritis (PsA) and ankylosing spondylitis (AS). This study examined the immunogenicity of secukinumab in patients with PsA and AS exposed to secukinumab for up to 52 weeks. Antibody bridging assays were used to assess the immunogenicit...